Quickly find business customer service phone numbers

All CSL support phone numbers are listed below, including customer service phone number(s), Headquarters support phone number(s), Media support phone number(s), Investor Relations support phone number(s), etc. You can also get CSL support via email, social networks, help center, or directly check all the customer service contacts of CSL.
Customer Service number
(Plasma-Derived Therapies)
+61 180 006 3892
Customer Service number
(Pharmaceuticals and Vaccines)
+61 180 000 8275
Customer Service number
(Computershare Outside Australia)
+6 139 415 4178
Customer Service number
(CSL Behring Pharmaceuticals (Toll Free within Australia))
+61 180 064 2865
Customer Service number
(CSL Behring Pharmaceuticals)
+6 480 064 0677
Customer Service number
(Seqirus Vaccines)
+6 480 050 2757
[Headquarters] support phone number +6 139 389 1911
[Media] support phone number +6 139 389 3425
[Investor Relations] support phone number +6 139 389 3470
[Media] support phone number
(Bern, Switzerland)
+4 131 344 1124
[Media] support phone number
(Kankakee, Illinois, USA)
+1 815 935 3120
[Media] support phone number
(Marburg, Germany)
+491 515 843 8860
[Media] support phone number
(Broadmeadows, Victoria, Australia)
+6 142 960 9762
[Media] support phone number
(Corporate and Immunology Inquiries)
+1 610 878 4468
[Media] support phone number
(Hematology, Respiratory and Transplant Inquiries)
+1 610 878 4802
[Media] support phone number
(Corporate Inquiries, Europe)
+49 693 051 7169

CSL Overview

Delivering on promises is what we do at CSL. More than a century ago, we made a promise to save lives and protect the health of people who were stricken with a range of serious and chronic medical conditions. Today, as a leading global biotechnology company, that same promise has never been stronger. We provide life-saving medicines in more than 60 nations with over 17,000 employees worldwide. CSL is driven to develop and deliver a broad range of life-saving medicines to treat disorders such as haemophilia and primary immune deficiencies, and vaccines to prevent influenza. Our therapies are also used in cardiac surgery, organ transplantation and burn treatment. Innovation has been in the DNA of CSL since our beginning in 1916 and continues as the core of everything we do today. Innovation spans our company — reflected in our 1,100 dedicated scientists who focus on solving patients’ unmet needs every day. As a global leader, CSL collaborates and supports patient and medical communities by improving access to therapies, advancing scientific knowledge, supporting future medical researchers, and engaging our staff in the support of local communities. Our world-class commercial operation, combined with a large and focused R&D team and operational excellence, enable us to accurately identify, successfully develop, and dependably deliver innovations that patients and providers want. CSL has earned a reputation as a passionate yet responsible organization driven to care for patients and deliver on its commitments. Today, our future has never looked brighter.
Industry Biotechnology Research
Headquarters Melbourne, VIC
Company size 10,001+ employees
Website http://www.csl.com

Top